18 Results for "

Nicotine addiction

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "Nicotine addiction" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-135783
CAS No.: 1314801-63-2
Purity:  99.94%
AT 1001 is an orally effective α3β4 nicotinic acetylcholine receptor (α3β4 nAChR) antagonist with a Ki value of 2.64 nM. AT 1001 reversibly blocks Epibatidine (HY-101078)-induced inward currents in HEK cells transfected with α3β4 nAChR. AT 1001 dose-dependently blocks nicotine self-administration behavior in rats, alleviates gluten-induced gastrointestinal symptoms, blocks tight junction toxin-induced immune responses, and reduces the incidence of type 1 diabetes in rats. AT 1001 can be used in the research of nicotine addiction and celiac disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103673
CAS No.: 2139356-35-5
Purity:  99.52%
Target:  

Adenosine Deaminase

Research Areas:  

Neurological Disease

AMPD2 inhibitor 1 is an adenosine monophosphate deaminase 2 (AMPD2) inhibitor, used in the research of sugar craving, salt craving, umami craving, and addictions including agent, tobacco, nicotine and alcohol addictions.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107457
CAS No.: 1092453-15-0
Purity:  98.02%
Target:  

mGluR

Research Areas:  

Neurological Disease

AZD-8529 is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107457A
CAS No.: 1314217-69-0
Purity:  99.63%
Target:  

mGluR

Research Areas:  

Neurological Disease

AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes .
loading...
    loading...
Cat. No.: HY-147428
CAS No.: 188125-42-0
Purity:  99.29%
Synonyms: MM-110; (±)​-18-Methoxycoronaridine
Target:  

nAChR Parasite

Research Areas:  

Infection Neurological Disease

Zolunicant (MM-110) is a potent inhibitor against nicotinic α3β4 receptors with an IC50 of 0.90 μM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse . Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis .
loading...
    loading...
Cat. No.: HY-103475
CAS No.: 39069-52-8
Purity:  99.72%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GS39783 is a positive allosteric modulator (PAM) of GABABR. Positive modulation of the GABABR can be used for the research of Nicotine addiction .
loading...
    loading...
Cat. No.: HY-110168
CAS No.: 913830-15-6
Purity:  98.36%
Target:  

nAChR

NS 9283 (A-969933) is a α4β2 nicotinic acetylcholine receptor (α4β2 nAChR) positive allosteric modulator that preferentially targets the (α4)3 (β2)2 stoichiometric conformation. NS 9283 increases the potency of ACh-induced currents without enhancing the maximal effect of ACh. NS 9283 also enhances prefrontal glutamate release, modulates attention-related electrophysiological responses, and potentiates the antinociceptive effects associated with α4β2 nAChR agonists. NS 9283 can be used in research related to inflammatory pain, postoperative pain, osteoarthritis pain, and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-110168R
CAS No.: 913830-15-6
NS 9283 (Standard) is the analytical standard of NS 9283 (HY-110168). This product is intended for research and analytical applications. NS 9283 (A-969933) is a α4β2 nicotinic acetylcholine receptor (α4β2 nAChR) positive allosteric modulator that preferentially targets the (α4)3 (β2)2 stoichiometric conformation. NS 9283 increases the potency of ACh-induced currents without enhancing the maximal effect of ACh. NS 9283 also enhances prefrontal glutamate release, modulates attention-related electrophysiological responses, and potentiates the antinociceptive effects associated with α4β2 nAChR agonists. NS 9283 can be used in research related to inflammatory pain, postoperative pain, osteoarthritis pain, and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-171746
CAS No.: 72120-72-0
Synonyms: 4,5,6,7-Tetrafluoro-L-tryptophan
Target:  

nAChR

Research Areas:  

Neurological Disease

F4-Trp (4,5,6,7-Tetrafluoro-L-tryptophan) is a ligand targeting the α3β4 nicotinic acetylcholine receptor (α3β4 nAChR). F4-Trp is promising for research of neurotransmission, addiction, and related diseases, such as neurological diseases .
loading...
    loading...
Cat. No.: HY-124110
CAS No.: 1975146-56-5
Target:  

nAChR

Research Areas:  

Neurological Disease

TC299423 is an orally active, brain-penetrant, selective and potent agonist for α6β2 ? and α4β2 ? nicotinic acetylcholine receptors (nAChRs) with anxiolytic and antinociceptive properties. TC299423 acts primarily through α6β2 ? nAChRs that are implicated in the anxiolytic effects of nicotine. TC299423 elicits reward-related behavior mediated through α6β2 ? nAChRs in hypersensitive α6L90’S mice. TC299423 elicits dopamine release and dose not suppress nicotine self-administration in rats. TC299423 is proming for rasearch of addiction and Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-137231B
CAS No.: 2934318-93-9
Purity:  98.10%
Target:  

nAChR

Research Areas:  

Neurological Disease

(S)-UFR2709 (hydrochloride) is a competitive nAChR antagonist?and displays higher affinity for α4β2 nAChRs than for α7 nAChRs. (S)-UFR2709 (hydrochloride) decreases anxiety and reduces ethanol consumption and ethanol preference in alcohol-preferring rats. (S)-UFR2709 (hydrochloride) acts as an anxiolytic agent and can be used for the study of nicotine addiction .
loading...
    loading...
Cat. No.: HY-14565
CAS No.: 161417-03-4
Synonyms: ABT-089
Target:  

nAChR

Research Areas:  

Neurological Disease

Pozanicline (ABT-089) selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a novel cholinergic agent that is a partial agonist at α4β2* nAChRs (Ki=16 nM) and shows high selectivity for α6β2* and α4α5β2 nAChR subtypes, the binding affinity (Ki, rat) for Pozanicline to [ 3H] cytisine sites is 16.7 nM. Pozanicline reverses nicotine withdrawal-induced cognitive deficits, may be an effective component of novel therapeutic strategies for nicotine addiction .
loading...
    loading...
Cat. No.: HY-120946
CAS No.: 1434047-61-6
Target:  

nAChR

Research Areas:  

Neurological Disease

VMY-2-95 is an oral active and blood-brain barrier (BBB) penetrant α4β2 nicotinic acetylcholine receptor desensitizer. VMY-2-95 can be used for study of depression or addiction .
loading...
    loading...
Cat. No.: HY-137231A
CAS No.: 1431628-22-6
Target:  

nAChR

Research Areas:  

Neurological Disease

(S)-UFR2709 is a competitive nAChR antagonist and displays higher affinity for α4β2 nAChRs than for α7 nAChRs. (S)-UFR2709 decreases anxiety and reduces ethanol consumption and ethanol preference in alcohol-preferring rats. (S)-UFR2709 acts as an anxiolytic agent and can be used for the study of nicotine addiction .
loading...
    loading...
Cat. No.: HY-10019AS1
Varenicline-d4 hydrochloride is a deuterium labeled Varenicline (dihydrochloride) (HY-10019A) . Varenicline (CP 526555) dihydrochloride is a potent partial agonist for α4β2 nicotinic acetylcholine receptor (nAChR) with an EC50 value of 2.3 μM. Varenicline dihydrochloride is a full agonist for α3β4 and α7 nAChRs with EC50 values of 55 μM and 18 μM, respectively . Varenicline dihydrochloride is a nicotinic ligand based on the structure of cytosine, and has the potential for smoking cessation treatment .
loading...
    loading...
Cat. No.: HY-103673R
CAS No.: 2139356-35-5
AMPD2 inhibitor 1 (Standard) is the analytical standard of AMPD2 inhibitor 1 (HY-103673). This product is intended for research and analytical applications. AMPD2 inhibitor 1 is an adenosine monophosphate deaminase 2 (AMPD2) inhibitor, used in the research of sugar craving, salt craving, umami craving, and addictions including agent, tobacco, nicotine and alcohol addictions.
loading...
    loading...
Cat. No.: HY-107457AR
CAS No.: 1314217-69-0
Research Areas:  

Neurological Disease

AZD-8529 mesylate (Standard) is the analytical standard of AZD-8529 (mesylate) (HY-107457A). This product is intended for research and analytical applications. AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes .
loading...
    loading...
Cat. No.: HY-110168S
NS 9283-d4 is the deuterated-labeled NS 9283 (HY-110168). NS 9283 (A-969933) is a α4β2 nicotinic acetylcholine receptor (α4β2 nAChR) positive allosteric modulator that preferentially targets the (α4)3 (β2)2 stoichiometric conformation. NS 9283 increases the potency of ACh-induced currents without enhancing the maximal effect of ACh. NS 9283 also enhances prefrontal glutamate release, modulates attention-related electrophysiological responses, and potentiates the antinociceptive effects associated with α4β2 nAChR agonists. NS 9283 can be used in research related to inflammatory pain, postoperative pain, osteoarthritis pain, and Parkinson's disease .
loading...
    loading...
  • 1